Satavaptan Cirrhotic Ascites Treatment Study: A Double-Blind, Randomized, Parallel Group Comparison of Treatment with Satavaptan at 5 to 10 mg daily Versus Placebo on top of Conventional Treatment in Patients with Ascites due to Cirrhosis of the Liver

  • Koch, Alvaro (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/0712/31/09